PetMed Express, Inc. (PETS)
Company Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands.
The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Country | United States |
Founded | 1996 |
Industry | Pharmaceutical Retailers |
Sector | Healthcare |
Employees | 302 |
CEO | Mathew N. Hulett |
Contact Details
Address: 420 South Congress Avenue Delray Beach, Florida 33445 United States | |
Phone | (561) 426-4444 |
Website | 1800petmeds.com |
Stock Details
Ticker Symbol | PETS |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001040130 |
CUSIP Number | 716382106 |
ISIN Number | US7163821066 |
Employer ID | 65-0680967 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Mathew N. Hulett | Chief Executive Officer, President and Director |
Christine Chambers | Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer and Secretary |
Mark Moseley | Chief Technology and Information Officer |
Daniel Job Pingree | Chief Marketing Officer |
Jacqueline Smith | Vice President of People |
Wendy Zalai | Corporate Controller and Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 15, 2024 | 8-K | Current Report |
Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 9, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Feb 8, 2024 | 8-K | Current Report |
Jan 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 8, 2024 | 8-K | Current Report |
Oct 31, 2023 | 10-Q | Quarterly Report |
Oct 30, 2023 | 8-K | Current Report |
Aug 30, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |